Literature DB >> 7876380

In vitro bromodeoxyuridine labelling of renal biopsy specimens: correlation between labelling indices and tubular damage.

K V Prasad1, J Wheeler, H Robertson, W H MaWhinney, M I McHugh, A R Morley.   

Abstract

AIMS: To examine the correlation between bromodeoxyuridine (BrdU) labelling indices (LI) and tubular damage in renal biopsy specimens; to evaluate the diagnostic and prognostic potential of measuring cell proliferation in a variety of renal lesions.
METHODS: In vitro BrdU labelling of renal biopsy specimens was undertaken and labelled cells were detected in routinely fixed, paraffin wax embedded sections by immunohistochemistry. The BrdU LI were calculated as percentages for the three types of tubular cells--proximal and distal convoluted tubules and medulla (LI/PCT, LI/DCT, LI/Med)--and a total tubular BrdU LI (LI/Tub) was also calculated for each biopsy specimen. Histological features indicative of tubular damage were also scored and a total tubular damage score obtained for each biopsy specimen.
RESULTS: The one hour labelling process did not affect tissue morphology or impede subsequent diagnosis. Four biopsy specimens were obtained from three renal transplant recipients. Diagnosis of 19 non-transplant biopsy specimens revealed a variety of renal lesions. Total tubular damage scores ranged from 0 to 25 and the LI/Tub ranged from 0 to 3.68% in all 23 biopsy specimens. Analyses of variance showed highly significant correlations between the total tubular damage score and both LI/Tub (p = 0.004) and LI/PCT (p = 0.004); a weaker correlation was found between the total tubular damage score and LI/DCT (p = 0.013).
CONCLUSIONS: A correlation was found between tubular damage and BrdU LI. This was most clearly seen in the proximal tubules. However, as the study was limited to a few examples of specific forms of glomerular or interstitial disease, firm conclusions about the value of BrdU labelling in routine diagnosis and prognosis could not be drawn.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7876380      PMCID: PMC502198          DOI: 10.1136/jcp.47.12.1085

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  Immunocytochemical detection of in vitro incorporated 5-bromodeoxyuridine in paraffin sections of human skin.

Authors:  H H Wolff; W Gnas
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

2.  International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology.

Authors:  K Solez; R A Axelsen; H Benediktsson; J F Burdick; A H Cohen; R B Colvin; B P Croker; D Droz; M S Dunnill; P F Halloran
Journal:  Kidney Int       Date:  1993-08       Impact factor: 10.612

3.  In situ demonstration of tissue proliferative activity using anti-bromo-deoxyuridine monoclonal antibody.

Authors:  S Veronese; M Gambacorta; B Falini
Journal:  J Clin Pathol       Date:  1989-08       Impact factor: 3.411

4.  In vivo bromodeoxyuridine incorporation in normal mouse kidney: immunohistochemical detection and measurement of labelling indices.

Authors:  H Robertson; J Wheeler; A R Morley
Journal:  Histochem J       Date:  1990-04

5.  In vivo bromodeoxyuridine incorporation in human gastric cancer: a study on formalin-fixed and paraffin-embedded sections.

Authors:  M Danova; A Riccardi; S Brugnatelli; R Fiocca; M Girino; L Villani; P Giordano; P Dionigi; M Giordano; R Buttini
Journal:  Histochem J       Date:  1988-03

6.  Immunohistochemical detection of bromodeoxyuridine in formalin-fixed tissues.

Authors:  H Sugihara; T Hattori; M Fukuda
Journal:  Histochemistry       Date:  1986

7.  Anti-glomerular basement membrane glomerulonephritis (anti-GBM GN) in the mouse: BrdU-labelling indices and histological damage.

Authors:  J Wheeler; H Robertson; A R Morley; D R Appleton
Journal:  Int J Exp Pathol       Date:  1993-02       Impact factor: 1.925

8.  Measurement of the S-phase duration in normal and abnormal human endometrium by in vitro double labelling with bromodeoxyuridine and tritiated thymidine.

Authors:  J G Thornton; M Wells; W J Hume
Journal:  J Pathol       Date:  1989-02       Impact factor: 7.996

9.  Cell kinetics of mouse kidney using bromodeoxyuridine incorporation and flow cytometry: preparation and staining.

Authors:  G D Wilson; J A Soranson; A A Lewis
Journal:  Cell Tissue Kinet       Date:  1987-03

10.  Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication.

Authors:  H G Gratzner
Journal:  Science       Date:  1982-10-29       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.